Summary
The kinetics and disposition of chloroquine (CQ) and its metabolite monodesethylchloroquine (CQM) were investigated in 5 healthy volunteers after incremental (150–300–600 mg CQ base) single oral doses of CQ. The analytical method used (HPLC and fluorescence detection) is the most sensitive known method for CQ and CQM. Plasma and whole blood concentrations of CQ, CQM and a third metabolite, bidesethylchloroquine (CQMM), were determined. The kinetics of CQ was found to be unique. The best fit was obtained by a multicompartmental model. The biological half-life appeared to be between 30–60 days; the volume of distribution (Vd) was ∼ 800l/kg, and the clearance ∼ 11/h/kg when calculated from plasma data. The whole blood concentrations were ∼ 8–10 times higher than in plasma, and consequently the Vd and whole blood clearance were ∼ 10 times lower. The kinetics changed as the dose was increased. An indication of capacity-limited steps in CQ disposition was found, as the rate constants decreased even though the clearance remained the same. The intrinsic half-life of CQM was 1/4 of that of CQ, but was prolonged after the highest dose of CQ. The present knowledge of CQ kinetics could provide a basis for revision of current dosage regimens in malaria suppression and rheumatoid disease to ensure efficacious and safe therapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alvan G, Ekman L, Lindström B (1982) Determination of chloroquine and its desethylmetabolite in plasma, red blood cells and urine by liquid chromatography. J Chromatogr 229:241–247
Berliner RW, Earle DP, Taggart IV, Zubrod G, Welch WI, Conan NI, Bauman E, Scudder ST, Shannon JA (1948) Studies in the chemotherapy of the human malarias IV. The physiological disposition. Antimalarial activity and toxicity of several derivatives of 4-aminoquinoline. J Clin Invest 27:98–107
Bergqvist Y, Frisk-Holmberg M (1980) Sensitive method for the determination of chloroquine and its metabolite desethylchloroquine in human plasma and urine by high performance liquid chromatography. J Chromatogr 221:119–127
Bergqvist Y, Domeij-Nyberg B (1983) Distribution of chloroquine and its metabolite desethylchloroquine in human blood cells and its implication for the quantitative determination of these compounds in serum and plasma. J Chromatogr 272:137–148
Brown ND, Poon BT, Chulay ID (1982) Determination of chloroquine and its deethylated metabolites in human plasma by ion pair high performance liquid chromatography. J Chromatogr 229:248–254
Bruce-Chwatt LI (1982) Chemoprophylaxis of malaria in Africa: “the spent magic bullet”. Br Med J 285:674–676
Chan K (1982) A simple integrated method for drug and derived metabolite kinetics. Drug Metab Dispos 10:474–479
Costae F (1970) Uberblick über die medikamentöse Behandlungen der rheumatischen Erkrankungen. In: Schoen T, Boni A, Miehlke K (eds) Klinik der rheumatischen Erkrankungen. Springer New York, pp 471–488
Desjardins RE, Pamplin CL, von Bredow I, Barey KG, Canfieled CI (1976) Kinetics of a new antimalarial mefloquine. Clin Pharmacol Ther 26:372–379
Essien EE, Afamefuna GL (1982) Chloroquine and its metabolites in human cord blood. Neonatal blood and urine after material medication. Clin Chem 28:1148–1157
Grundman M, Vrublovsky P, Demkova V, Mikulikova I, Pergrimova E (1972) Tissue distribution and urinary excretion of chloroquine in rats. Arzneimittelforsch 22:82–88
Faehlman M, Rombo L, Hedman P (1981) Serum concentrations of chloroquine in a patient with late recrudescence of Kenyan Plasmodium falcipurum malaria. Trans Roy Soc Trop Med Hyg 75:362–364
Frisk-Holmberg M, Bergqvist Y, Domeij-Nyberg B, Hellström L, Jansson F (1979) Chloroquine serum concentrations and side effects, evidence for dose dependent kinetics. Clin Pharmacol Ther 25:345–350
Frisk-Holmberg M, Bergqvist Y (1982) Chloroquine disposition in man. Br J Clin Pharmacol [Suppl] 14:624–626
Frisk-Holmberg M, Bergqvist Y, Domeij-Nyberg B (1983) Steady state disposition of chloroquine in patients with rheumatoid disease. Eur J Clin Pharmacol 24:837–839
Kuroda K (1962) Detection and distribution of chloroquine metabolites in human tissues. J Pharmacol Exp Ther 137:156–161
Lindqvist NG (1973) Accumulation of drugs in melanin. Acta Radiol Scand [Suppl] 325:1–91
McChesney EW, Banks WF, McAuliff AB (1962) Laboratory studies of the 4-aminoquinoline antimalarials: plasma levels of chloroquine and hydroxy chloroquine in man after various oral dosage regimens. Antibiot Chemother 12:583–594
McChesney EW, Conway WD, Banks WF, Rogers JE, Shehoshy IM (1966) Studies on the metabolism of some compounds of the 4-amino 7-chloroquinoline series. J Pharmacol Exp Ther 151:483–493
McChesney EW, Fasco MI, Banks WF (1967) The metabolism of chloroquine in man during and after repeated oral dosage. J Pharmacol Exp Ther 158:323–331
Metzier GL, Elfring G, McEwen AJ (1974) A package of computer programs for pharmacokinetic modeling. Biometrics, September, p 562
Nagashima R, Levy G, O'Reilly RA (1968) Comparative pharmacokinetics of coumarin anticoagulants IV. Application of three compartmental models to the analysis of the dose dependent kinetic of bishydroxycoumarin elimination. Pharm Sci 57:1888–1895
Price-Evans DA, Fletcher KA, Baty ID (1979) The urinary excretion of chloroquine in different ethnic groups. Ann Trop Med Parasitol 73:11–17
Riegelman S, Collier PI (1980) The application of statistical moment theory to an evaluation of in vivo dissolution time and absorption time. J Pharmacokinet Biopharm 6:509–534
Rietschel WA, Hammer GV, Thomson GA (1978) Pharmacokinetics of antimalarias and proposals for dosage regimens. J Clin Pharmacol 16:395–401
Rollo IM (1980) Drugs used in the chemotherapy of malaria. In: Goodman IS, Gilman A (eds) The pharmacological basis of therapeutics, 6th edn. Mac Millan, New York, pp 1038–1060
Rossum v IM, Burgers I, van Lingen G, Bie de I (1983) Pharmacokinetics a dynamic system approach. Trends Pharmacol Sci 12:127–130
Wagner IC (1979) Fundamentals of clinical pharmacokinetics. Drug Intelligence Publications, Hamilton
Walker O, Alvan G, Burman B, Gustavsson L, Lindström G, Sjöqvist F (1982) The pharmacokinetics of chloroquine in healthy volunteers. Br J Clin Pharmacol [Suppl] 14:623
Walter O, Brikett DI, Alvan G, Gustavsson LG, Sjöqvist F (1983) Characterization of chloroquine plasma protein binding in man. Br J Clin Pharmacol 272:137–143
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Frisk-Holmberg, M., Bergqvist, Y., Termond, E. et al. The single dose kinetics of chloroquine and its major metabolite desethylchloroquine in healthy subjects. Eur J Clin Pharmacol 26, 521–530 (1984). https://doi.org/10.1007/BF00542151
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00542151